To no one’s surprise and to the benefit of your portfolio should you have one, even if all in mutual funds, Anthropic and Mr. Market partied all day. ANT started the day at 11.30am ET at $83/share, peaked at $111.50 per share, and closed at $97.17 which is a 17% first day gain. It was the largest first day ever in the history of the US markets.
Anthropic raised $81.3 billion with a new valuation of $1.5 trillion. Over at the financial channels, the partying was like 1999. (No TV in 1928). Yet the Dow Jones closed below 50,000 for the first time since June. AI and chips are still in the doldrums and ANT didn’t much change that. Where’s Prince now for the soundtrack? Yahoo Finance, CNBC
Consumer longevity platform Hone Health raises $228 million. Their financing structure is interesting and a little complicated. The current financing led to a reveal of a previously undisclosed Series A, with $28 million raised as an extension of the Series A and the remaining $200 million as growth financing from General Catalyst’s Customer Value Fund (CVF). The lead for the Series A is MarcyPen Capital Partners, with additional participation from Pentland Ventures, Kinship Ventures co-founded by Gwyneth Paltrow and Moj Mohdara, Hanwha, Gannet Capital, humbition, Comma Capital, and ID Ventures. The new funding will be used in five areas: broader clinical care, advanced diagnostics, clinical technology, emerging therapies, and research and trials. A basic biomarker test starts at $65 and is not covered by insurance. Most of their services are available only to members, which start at $25/month (Basic), $135/month (Plus), or $155/month (Premium). Release, MedCity News
Their other big launch is Hone Black, a concierge platform emphasizing whole body care and a select team of doctors. That will run the eager longevity maven $1,250 per month, billed annually at $15,000 per year. With an endorsement from Gwyneth Paltrow, who despite Goop is a savvy moneymaker, one can suss out that Hone is one of those very elite services Not For The Masses.
Australian practice scribe/documenter Heidi Health has fallen into a few mountain crevasses. The Melbourne-headquartered global company laid off 18% of staff (108 of approximately 600 employees). The layoffs come a day after cofounders Waleed Mussa and Yu Liu departed the company as planned. Dr. Thomas Kelly will remain as CEO in the restructuring which is cited as improving alignment of staffing and investment with company growth priorities, an otherwise anodyne statement.
Ironically, in September Heidi had successfully landed a A$475 million financing package consisting of a $100 million Series C round and a separate $240 million growth financing facility. September also marked the launch of AI agents to plan and execute tasks such as pre-charting, referral communications, panel reviews and follow-up work across EHRs, calendars, inboxes and patient portals. The layoffs affect customer service, which will move into product teams, and R&D will be reorganized. There is no word on what areas of the global operation will be most affected. Mobihealthnews, HLTH
Aevius launches with a $22 million seed round investment. The Mass General Brigham spinout for clinical intelligency was financed by Insight Partners. The platform creates AI models that turn structured, unstructured, and “specialty multimodal” clinical data from healthcare, payer and life sciences organizations into useful information for them, across different systems, formats and medical vocabularies to build a comprehensive picture of each patient. Potential uses include care planning, population analysis, biomarker identification and clinical trial recruitment. The funding from Insight Partners will be used for continued model and product development, expansion of the company’s engineering, clinical and commercial teams, and commercial deployment. Release, Mobihealthnews







Leave a Reply